On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Clinical guidelines for the management of depression recommend psychological treatments organised in a stepped care pathway, where patients can access progressively intensive treatments in a sequential way. Stratified care follows principles of precision medicine, and involves selecting the intensity of treatment in a personalised way, based on each patient’s characteristics and expected prognosis.
The StratCare Trial involved 30 clinicians working across four IAPT psychological therapy teams; and they were randomly assigned to a stratified (n=15) or stepped care (treatment as usual, n=15) group. All clinicians used the same interview schedule to conduct assessments with patients seeking treatment for common mental health problems, but those in the stratified care group received a personalised treatment recommendation for each patient – generated by a prognostic machine learning algorithm. In total, n=950 eligible patients received either stratified (n=582) or stepped (n=368) care. The proportions of cases with a full remission of depression (PHQ-9) symptoms were compared between groups. Cost-effectiveness analysis compared treatment costs relative to patient-reported health outcomes.
This seminar will present the findings of the StratCare Trial and discuss implications for theory and practice.
